Yoo Duk Choi1, Seung Min Chun2, Sun A Jin2, Jee-Bum Lee2, Sook Jung Yun3. 1. Department of Pathology, Chonnam National University Medical School, Gwangju, Korea. 2. Department of Dermatology, Chonnam National University Medical School, Gwangju, Korea. 3. Department of Dermatology, Chonnam National University Medical School, Gwangju, Korea. Electronic address: sjyun@chonnam.ac.kr.
Abstract
BACKGROUND: Amelanotic acral melanoma (AAM) is very rare and difficult to diagnose both clinically and pathologically. Complete-type AAM shows no black to brown pigmentation in the lesion, whereas incomplete-type AAM shows focal or subtle pigmentation. AAM has been the subject of few investigations. OBJECTIVES: We analyzed the clinicopathological features, BRAF mutations, and KIT aberrations in 35 Korean AAM cases. METHODS: We included 28 cases of complete-type and 7 cases of incomplete-type AAM. RESULTS: In all, 26 AAMs (45.7%) were located on the feet of patients, 21 of which (82.9%) showed ulceration. Sixteen cases developed in subungual areas. Nodular melanoma was the most common histopathological subtype (63.6%). The most frequent cell types affected were epithelioid and spindled. HMB-45 staining was strongly positive in 66.7% of AAMs; 4 (12.1%) were negative for HMB-45, and 3 of these were complete-type AAMs. Of 33 total patients, BRAF mutations were detected in 2 AAM cases, and KIT aberrations were present in 11 cases (33.3%). Four cases (12.1%), all of which were complete-type AAMs, had KIT mutations. KIT aberrations were weakly correlated with c-kit staining. Twenty patients were TNM stage I or II, and mean survival was 30.14 ± 4.54 months. LIMITATIONS: The study is limited by the small number of patients. CONCLUSION: Physicians should be aware of rare and hard-to-diagnose AAMs. We expect that tyrosine kinase inhibitors would be effective for KIT-mutated patients with complete-type AAMs.
BACKGROUND:Amelanotic acral melanoma (AAM) is very rare and difficult to diagnose both clinically and pathologically. Complete-type AAM shows no black to brown pigmentation in the lesion, whereas incomplete-type AAM shows focal or subtle pigmentation. AAM has been the subject of few investigations. OBJECTIVES: We analyzed the clinicopathological features, BRAF mutations, and KIT aberrations in 35 Korean AAM cases. METHODS: We included 28 cases of complete-type and 7 cases of incomplete-type AAM. RESULTS: In all, 26 AAMs (45.7%) were located on the feet of patients, 21 of which (82.9%) showed ulceration. Sixteen cases developed in subungual areas. Nodular melanoma was the most common histopathological subtype (63.6%). The most frequent cell types affected were epithelioid and spindled. HMB-45 staining was strongly positive in 66.7% of AAMs; 4 (12.1%) were negative for HMB-45, and 3 of these were complete-type AAMs. Of 33 total patients, BRAF mutations were detected in 2 AAM cases, and KIT aberrations were present in 11 cases (33.3%). Four cases (12.1%), all of which were complete-type AAMs, had KIT mutations. KIT aberrations were weakly correlated with c-kit staining. Twenty patients were TNM stage I or II, and mean survival was 30.14 ± 4.54 months. LIMITATIONS: The study is limited by the small number of patients. CONCLUSION: Physicians should be aware of rare and hard-to-diagnose AAMs. We expect that tyrosine kinase inhibitors would be effective for KIT-mutated patients with complete-type AAMs.
Authors: James V Neiswender; Robert L Kortum; Caitlin Bourque; Melissa Kasheta; Leonard I Zon; Deborah K Morrison; Craig J Ceol Journal: Cancer Res Date: 2017-09-25 Impact factor: 12.701
Authors: Yian Ann Chen; Jamie K Teer; Zeynep Eroglu; Jheng-Yu Wu; John M Koomen; Florian A Karreth; Jane L Messina; Keiran S M Smalley Journal: Semin Cancer Biol Date: 2019-11-02 Impact factor: 15.707
Authors: Natasa Broit; Peter A Johansson; Chloe B Rodgers; Sebastian T Walpole; Nicholas K Hayward; Antonia L Pritchard Journal: Pigment Cell Melanoma Res Date: 2022-03-07 Impact factor: 4.159
Authors: Sara S Bernardes; Ingrid Ferreira; David E Elder; Aretha B Nobre; Héctor Martínez-Said; David J Adams; Carla Daniela Robles-Espinoza; Patricia A Possik Journal: J Pathol Clin Res Date: 2021-07-02